These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 7570656)

  • 21. Chemical mixture toxicology: from descriptive to mechanistic, and going on to in silico toxicology.
    Yang RS; El-Masri HA; Thomas RS; Dobrev ID; Dennison JE; Bae DS; Campain JA; Liao KH; Reisfeld B; Andersen ME; Mumtaz M
    Environ Toxicol Pharmacol; 2004 Nov; 18(2):65-81. PubMed ID: 21782736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluating pharmacokinetic and pharmacodynamic interactions with computational models in supporting cumulative risk assessment.
    Tan YM; Clewell H; Campbell J; Andersen M
    Int J Environ Res Public Health; 2011 May; 8(5):1613-30. PubMed ID: 21655141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigation of the potential impact of benchmark dose and pharmacokinetic modeling in noncancer risk assessment.
    Clewell HJ; Gentry PR; Gearhart JM
    J Toxicol Environ Health; 1997 Dec; 52(6):475-515. PubMed ID: 9397182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of in vitro data in developing a physiologically based pharmacokinetic model: Carbaryl as a case study.
    Yoon M; Kedderis GL; Yan GZ; Clewell HJ
    Toxicology; 2015 Jun; 332():52-66. PubMed ID: 24863738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A PBPK modeling-based approach to account for interactions in the health risk assessment of chemical mixtures.
    Haddad S; Béliveau M; Tardif R; Krishnan K
    Toxicol Sci; 2001 Sep; 63(1):125-31. PubMed ID: 11509752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biologically motivated quantitative models and the mixture toxicity problem.
    Conolly RB
    Toxicol Sci; 2001 Sep; 63(1):1-2. PubMed ID: 11509736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Applications of computational toxicology methods at the Agency for Toxic Substances and Disease Registry.
    el-Masri HA; Mumtaz MM; Choudhary G; Cibulas W; De Rosa CT
    Int J Hyg Environ Health; 2002 Mar; 205(1-2):63-9. PubMed ID: 12018017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Moving from external exposure concentration to internal dose: duration extrapolation based on physiologically based pharmacokinetic derived estimates of internal dose.
    Simmons JE; Evans MV; Boyes WK
    J Toxicol Environ Health A; 2005 Jun 11-25; 68(11-12):927-50. PubMed ID: 16020185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Public health guidance values for chemical mixtures: current practice and future directions.
    Pohl HR; Hansen H; Chou CH
    Regul Toxicol Pharmacol; 1997 Dec; 26(3):322-9. PubMed ID: 9441922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physiologically based pharmacokinetic analyses of simple mixtures.
    Krishnan K; Clewell HJ; Andersen ME
    Environ Health Perspect; 1994 Nov; 102 Suppl 9(Suppl 9):151-5. PubMed ID: 7698076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physiological modeling and extrapolation of pharmacokinetic interactions from binary to more complex chemical mixtures.
    Krishnan K; Haddad S; Béliveau M; Tardif R
    Environ Health Perspect; 2002 Dec; 110 Suppl 6(Suppl 6):989-94. PubMed ID: 12634130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Probabilistic dose-response modeling: case study using dichloromethane PBPK model results.
    Marino DJ; Starr TB
    Regul Toxicol Pharmacol; 2007 Dec; 49(3):285-300. PubMed ID: 17949874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploration of an interaction threshold for the joint toxicity of trichloroethylene and 1,1-dichloroethylene: utilization of a PBPK model.
    el-Masri HA; Tessari JD; Yang RS
    Arch Toxicol; 1996; 70(9):527-39. PubMed ID: 8831903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experimental and mathematical modeling methods for the investigation of toxicological interactions.
    El-Masri HA
    Toxicol Appl Pharmacol; 2007 Sep; 223(2):148-54. PubMed ID: 16996550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Six interaction profiles for simple mixtures.
    Pohl HR; Roney N; Wilbur S; Hansen H; De Rosa CT
    Chemosphere; 2003 Oct; 53(2):183-97. PubMed ID: 12892681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A proposed approach to study the toxicology of complex mixtures of petroleum products: the integrated use of QSAR, lumping analysis and PBPK/PD modeling.
    Verhaar HJ; Morroni JR; Reardon KF; Hays SM; Gaver DP; Carpenter RL; Yang RS
    Environ Health Perspect; 1997 Feb; 105 Suppl 1(Suppl 1):179-95. PubMed ID: 9114286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of physiologically based pharmacokinetic modelling to combination toxicology.
    Simmons JE
    Food Chem Toxicol; 1996; 34(11-12):1067-73. PubMed ID: 9119317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physiologically based pharmacokinetic models for trichloroethylene and its oxidative metabolites.
    Fisher JW
    Environ Health Perspect; 2000 May; 108 Suppl 2(Suppl 2):265-73. PubMed ID: 10807557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Case study illustrating the WHO IPCS guidance on characterization and application of physiologically based pharmacokinetic models in risk assessment.
    Meek ME; Barton HA; Bessems JG; Lipscomb JC; Krishnan K
    Regul Toxicol Pharmacol; 2013 Jun; 66(1):116-29. PubMed ID: 23535119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Review of acute chemical incidents as a first step in evaluating the usefulness of physiologically based pharmacokinetic models in such incidents.
    Hunault CC; Boerleider RZ; Hof BG; Kliest JJ; Meijer M; Nijhuis NJ; de Vries I; Meulenbelt J
    Clin Toxicol (Phila); 2014 Feb; 52(2):121-8. PubMed ID: 24446967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.